TherapeuticsMD Is a Top Stock Under $10 for 2015: David Peltier
NEW YORK (TheStreet) - TheStreet's David Peltier, manager of the Stocks Under $10 portfolio, continues to unearth 2015's top stocks that trade for less than $10. His first pick wasBallantyne Strong (BTN) - Get Report , and now he's looking at TherapeuticsMD (TXMD) - Get Report .
Shares of the pharmaceutical company trade at about $4.25. Though the stock is down about 18% this year, Peltier believes it has upside in 2015.
TherapeuticsMD hasn't been able to keep pace with other biotech stocks this year, as the iShares Nasdaq Biotechnology Index ETF (IBB) - Get Report has climbed 35% and SPDR S&P Biotech ETF (XBI) - Get Report has risen 43.5% in 2014.
TherapeuticsMD TXMD data by YCharts
Peltier, however, said he believes that TherapeuticsMD can climb into the "high single digits" range. The company has a "solid" management team, he said, and has two female hormone replacement therapy treatments in Phase 3 clinical trials. Revenue rose 82% to $4.2 million in its latest quarter.
As an aside, Peltier has also dug up many of 2015's top dividend plays headed into the new year, including such stocks as Lockheed Martin (LMT) - Get Report , General Electric (GE) - Get Report , Tompkins Financial (TMP) - Get Report and Sonoco Products (SON) - Get Report .
-- Written by Bret Kenwell
This article is commentary by an independent contributor. At the time of publication, Kenwell was long GE.
